Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose

References

• Nicolas F Tiveron MC Davoust J Reggio H GPI membrane anchor is determinant in intracellular accumulation of apical plasma membrane proteins in the non-polarized human colon cancer cell line HT-29 18 J Cell Sci 1994 107 Pt 10 2679 2689 7876337
   PubMed Web of Science ®Google Scholar
• Duke-Cohan JS Morimoto C Rocker JA Schlossman SF A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26) J Biol Chem 1995 270 23 14107 14114 7539799
   PubMed Web of Science ®Google Scholar
• Yazbeck R Howarth GS Abbott CA Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends Pharmacol Sci 2009 30 11 600 607 19837468
   PubMed Web of Science ®Google Scholar
• Drucker DJ Nauck MA The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 2006 368 9548 1696 1705 17098089
   PubMed Web of Science ®Google Scholar
• Lamers D Famulla S Wronkowitz N Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome Diabetes 2011 60 7 1917 1925 21593202
   PubMed Web of Science ®Google Scholar
• Famulla S Schlich R Sell H Eckel J Differentiation of human adipocytes at physiological oxygen levels results in increased adiponectin secretion and isoproterenol-stimulated lipolysis Adipocyte 2012 1 3 132 181 23700522
   PubMedGoogle Scholar
• Gu N Tsuda M Matsunaga T Glucose regulation of dipeptidyl peptidase IV gene expression is mediated by hepatocyte nuclear factor-1alpha in epithelial intestinal cells Clin Exp Pharmacol Physiol 2008 35 12 1433 1439 18671716
   PubMed Web of Science ®Google Scholar
• Bauvois B Djavaheri-Mergny M Rouillard D Dumont J Wietzerbin J Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells Oncogene 2000 19 2 265 272 10645005
   PubMed Web of Science ®Google Scholar
• Mannucci E Pala L Ciani S Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus Diabetologia 2005 48 6 1168 1172 15864535
   PubMed Web of Science ®Google Scholar
• Varga T Somogyi A Barna G Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes Pathol Oncol Res 2011 17 4 925 930 21785903
   PubMed Web of Science ®Google Scholar
• Kim SJ Nian C Doudet DJ McIntosh CH Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice Diabetes 2008 57 5 1331 1339 18299314
   PubMed Web of Science ®Google Scholar
• Nagakura T Yasuda N Yamazaki K Ikuta H Tanaka I Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition Metabolism 2003 52 1 81 86 12524666
   PubMed Web of Science ®Google Scholar
• Thompson AC Nuñez M Davidson R Mitigation of isolation-associated adipocyte interleukin-6 secretion following rapid dissociation of adipose tissue J Lipid Res 2012 53 12 2797 2805 22911046
   PubMed Web of Science ®Google Scholar
• Sato T Kotake D Hiratsuka M Hirasawa N Enhancement of inflammatory protein expression and nuclear factor Kb (NF-Kb) activity by trichostatin A (TSA) in OP9 preadipocytes PLoS One 2013 8 3 e59702 23555753
   PubMed Web of Science ®Google Scholar
• Pala L Ciani S Dicembrini I Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions Diabet Med 2010 27 6 691 695 20546289
   PubMed Web of Science ®Google Scholar
• Ryskjaer J Deacon CF Carr RD Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake Eur J Endocrinol 2006 155 3 485 493 16914604
   PubMed Web of Science ®Google Scholar
• Sell H Blüher M Klöting N Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro Diabetes Care 2013 36 12 4083 4090 24130353
   PubMed Web of Science ®Google Scholar
• Matheeussen V Waumans Y Martinet W Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis Basic Res Cardiol 2013 108 3 350 23608773
   PubMed Web of Science ®Google Scholar
• Kirino Y Sato Y Kamimoto T Kawazoe K Minakuchi K Nakahori Y Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats J Endocrinol 2009 200 1 53 61 18931022
   PubMed Web of Science ®Google Scholar
• Li J Houseknecht KL Stenbit AE Katz EB Charron MJ Reduced glucose uptake precedes insulin signaling defects in adipocytes from heterozygous GLUT4 knockout mice FASEB J 2000 14 9 1117 1125 10834933
   PubMed Web of Science ®Google Scholar
• Wang Y Nishina PM Naggert JK Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng J Endocrinol 2009 203 1 65 74 19587264
   PubMed Web of Science ®Google Scholar
• Nacci C Tarquinio M De Benedictis L Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature Endocrinology 2009 150 2 849 861 18845644
   PubMed Web of Science ®Google Scholar
• Margoni A Perrea DN Vlachos I Serum leptin, adiponectin and tumor necrosis factor-α in hyperlipidemic rats with/without concomitant diabetes mellitus Mol Med 2011 17 1–2 36 40 20838752
   PubMed Web of Science ®Google Scholar
• Silva AP Cavadas C Baïsse-Agushi B Spertini O Brunner HR Grouzmann E NPY, NPY receptors, and DPP IV activity are modulated by LPS, TNF-alpha and IFN-gamma in HUVEC Regul Pept 2003 116 1–3 71 79 14599717
   PubMedGoogle Scholar